Epidemiology, associated burden, and current clinical practice for the diagnosis and management of Alzheimer’s disease in Japan
William Montgomery,1 Kaname Ueda,2 Margaret Jorgensen,3 Shari Stathis,3 Yuanyuan Cheng,3 Tomomi Nakamura2 1Global Patient Outcomes & Real World Evidence, Eli Lilly Australia, Sydney, NSW, Australia; 2Medical Development Unit-Japan, Eli Lilly Japan KK, Kobe, Japan; 3Health Technology...
Main Authors: | Montgomery W, Ueda K, Jorgensen M, Stathis S, Cheng Y, Nakamura T |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-12-01
|
Series: | ClinicoEconomics and Outcomes Research |
Subjects: | |
Online Access: | https://www.dovepress.com/epidemiology-associated-burden-and-current-clinical-practice-for-the-d-peer-reviewed-article-CEOR |
Similar Items
-
Detection, diagnosis, and treatment of Alzheimer’s disease dementia stratified by severity as reported by caregivers in Japan
by: Montgomery W, et al.
Published: (2018-07-01) -
Global economic burden of schizophrenia: response to authors’ reply
by: Neil AL, et al.
Published: (2017-02-01) -
Memantine: a review of studies into its safety and efficacy in treating Alzheimer’s disease and other dementias
by: Stuart J Thomas, et al.
Published: (2009-09-01) -
The Prevalence of Alzheimer’s Disease in China: A Systematic Review and Meta-analysis
by: Kanglan LI, et al.
Published: (2018-10-01) -
Association Between Psoriasis and Dementia: Current Evidence
by: Liu Liu, et al.
Published: (2020-10-01)